NCT01123876 Evaluating the Safety and Tolerability of the Poly-ADP Ribose (PARP) Inhibitor With FOLFIRI in Subjects With Solid Tumor Status COMPLETED Phase PHASE1
NCT01123473 Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer Status TERMINATED Phase PHASE2
NCT01100814 Expression of S100A2 and Trefoil Factor Family Members in Epstein-Barr Virus Related Gastric Cancer Status UNKNOWN Phase N/A
NCT01099085 Trial of XP (Capecitabine/CDDP) Simvastatin in Advanced Gastric Cancer Patients Status COMPLETED Phase PHASE3
NCT01090505 Study of S-1 and Oxaliplatin as Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer Status UNKNOWN Phase PHASE2
NCT01088204 Feasibility Study of Laparoscopy-assisted D2 Distal Gastrectomy to Treat Advanced Gastric Cancer Status UNKNOWN Phase PHASE2
NCT01070290 A Study of ARQ 197 Versus Investigator's Choice of Second-Line Chemotherapy in Patients With Locally Advanced or Metastatic Gastric Cancer Who Have Progressive Neoplastic Disease Following Treatment With One Prior Chemotherapy Regimen Status WITHDRAWN Phase PHASE2
NCT01065688 A Trial of Reconstruction After Distal Gastrectomy for Gastric Cancer Status COMPLETED Phase PHASE3
NCT01063517 Efficacy Study of Olaparib With Paclitaxel Versus Paclitaxel in Gastric Cancer Patients Status COMPLETED Phase PHASE2
NCT01059643 A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE2
NCT01048463 Effect of Enteral Nutrition Rich in Eicosapentaenoic Acid (EPA) on Patients Receiving Chemotherapy for GI Tumor Status UNKNOWN Phase PHASE3
NCT01045538 Study of Vorinostat Plus Capecitabine (X) and Cisplatin (P) for 1st Line Treatment of Metastatic or Recurrent Gastric Cancer: Zolinza+XP Status COMPLETED Phase PHASE1/PHASE2
NCT01041404 ToGA Study - A Study of Herceptin (Trastuzumab) in Combination With Chemotherapy Compared With Chemotherapy Alone in Patients With HER2-Positive Advanced Gastric Cancer Status COMPLETED Phase PHASE3
NCT01033695 Interobserver Agreement of Endoscopic Ultrasonography and Endoscopic Sonoelastography in the Evaluation of Lymph Nodes Status COMPLETED Phase N/A
NCT01002443 Efficacy Study of Helicobacter Pylori Eradication in Patients Undergoing Subtotal Gastrectomy for Gastric Cancer Status COMPLETED Phase PHASE2
NCT00985556 Oxaliplatin and S-1 or Oxaliplatin and Capecitabine in Treating Patients With Recurrent, Metastatic, or Unresectable Gastric Cancer Status UNKNOWN Phase PHASE2
NCT00985192 Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer Status COMPLETED Phase PHASE2
NCT00980603 Docetaxel Versus Docetaxel Plus Cisplatin Versus Docetaxel Plus S-1 as Second-line Chemotherapy in Metastatic Gastric Cancer Status UNKNOWN Phase PHASE2